Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report
Cardiobacterium hominis, a member of the HACEK group of organisms, is an uncommon but important cause of subacute bacterial endocarditis. First-line therapy is a third-generation cephalosporin due to rare beta-lactamase production. The authors report a case involving endovascular infection due to C...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2015/568750 |
id |
doaj-3830fce1aa744bb6b7aa6e713edb966e |
---|---|
record_format |
Article |
spelling |
doaj-3830fce1aa744bb6b7aa6e713edb966e2021-07-02T03:24:57ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322015-01-01261414310.1155/2015/568750Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case ReportDavie Wong0Julie Carson1Andrew Johnson2Internal Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaSection of Microbiology, Department of Pathology and Laboratory Medicine, University of Calgary, CanadaSection of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Alberta, CanadaCardiobacterium hominis, a member of the HACEK group of organisms, is an uncommon but important cause of subacute bacterial endocarditis. First-line therapy is a third-generation cephalosporin due to rare beta-lactamase production. The authors report a case involving endovascular infection due to C hominis that initially tested resistant to third-generation cephalosporins using an antibiotic gradient strip susceptibility method (nitrocephin negative), but later proved to be susceptible using broth microdilution reference methods (a ‘major’ error). There are limited studies to guide susceptibility testing and interpretive breakpoints for C hominis in the medical literature, and the present case illustrates some of the issues that may arise when performing susceptibility testing for fastidious organisms in the clinical microbiology laboratory.http://dx.doi.org/10.1155/2015/568750 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Davie Wong Julie Carson Andrew Johnson |
spellingShingle |
Davie Wong Julie Carson Andrew Johnson Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report Canadian Journal of Infectious Diseases and Medical Microbiology |
author_facet |
Davie Wong Julie Carson Andrew Johnson |
author_sort |
Davie Wong |
title |
Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report |
title_short |
Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report |
title_full |
Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report |
title_fullStr |
Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report |
title_full_unstemmed |
Subacute Bacterial Endocarditis Caused by Cardiobacterium hominis: A Case Report |
title_sort |
subacute bacterial endocarditis caused by cardiobacterium hominis: a case report |
publisher |
Hindawi Limited |
series |
Canadian Journal of Infectious Diseases and Medical Microbiology |
issn |
1712-9532 |
publishDate |
2015-01-01 |
description |
Cardiobacterium hominis, a member of the HACEK group of organisms, is an uncommon but important cause of subacute bacterial endocarditis. First-line therapy is a third-generation cephalosporin due to rare beta-lactamase production. The authors report a case involving endovascular infection due to C hominis that initially tested resistant to third-generation cephalosporins using an antibiotic gradient strip susceptibility method (nitrocephin negative), but later proved to be susceptible using broth microdilution reference methods (a ‘major’ error). There are limited studies to guide susceptibility testing and interpretive breakpoints for C hominis in the medical literature, and the present case illustrates some of the issues that may arise when performing susceptibility testing for fastidious organisms in the clinical microbiology laboratory. |
url |
http://dx.doi.org/10.1155/2015/568750 |
work_keys_str_mv |
AT daviewong subacutebacterialendocarditiscausedbycardiobacteriumhominisacasereport AT juliecarson subacutebacterialendocarditiscausedbycardiobacteriumhominisacasereport AT andrewjohnson subacutebacterialendocarditiscausedbycardiobacteriumhominisacasereport |
_version_ |
1721341582023589888 |